Literature DB >> 18191003

V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.

Lu Lu1, Yun Zhu, Junchen Diao, Zuguang Wang, Ying-Hua Chen.   

Abstract

Previous studies have found the close correlation between epitope density and epitope-specific response, which have shown that high epitope density in a single recombinant protein molecule significantly enhances the humoral response and protective immunity. However, it has not been determined whether this kind of high epitope density could also significantly influence T cell response. Based on this, a series of recombinant DNA and proteins were designed and prepared. Each molecule consists of various copy numbers of the V3 CTL epitope on HIV-1 gp120 (one, two, four and eight copies). Our results show clearly that different V3-epitope densities in just one single DNA or protein molecules have respectively different effects on the number and activity of both primary and memory T cells. Interestingly, this effect is more complex than that on the B cells: epitope density in one plasmid or protein antigen affects the number, not the cytotoxic avidity, of primary CD8+ T cells, but affects both the number and cytotoxic avidity of memory CD8+ T cells. It indicates epitope density in the antigen is an important consideration to optimize T cell response induction and may facilitate the development of effective T cell-based anti-virus vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191003     DOI: 10.1016/j.vaccine.2007.11.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Receptor binding domain based HIV vaccines.

Authors:  Huan Liu; Wenwen Bi; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

2.  Design and production of a multiepitope construct derived from hepatitis E virus capsid protein.

Authors:  Reza Taherkhani; Fatemeh Farshadpour; Manoochehr Makvandi
Journal:  J Med Virol       Date:  2015-03-17       Impact factor: 2.327

3.  A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains.

Authors:  Lu Lu; Chungen Pan; Yuan Li; Hong Lu; Wu He; Shibo Jiang
Journal:  Retrovirology       Date:  2012-12-07       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.